NEW YORK, NY--(Marketwire - May 17, 2010) - Anthony G. Viscogliosi, Chairman & CEO of Small Bone Innovations, Inc. (SBi), will address attendees at the BioMedGPS JointVentures Conference of owners and investors in early-to-mid stage medical technology companies in Chicago on June 14-15.
In addition to presenting SBi, the company he founded in 2005, Mr. Viscogliosi will also sit on a panel of venture capital experts chaired by William Plovanic of investment bankers Canaccord Adams. SBi has raised more than $200 million in private investment funds since its founding from a wide range of domestic and overseas investors.
SBi last year rolled out its Scandinavian Total Ankle Replacement (S.T.A.R.®) in the U.S. to cap an investment in more than 60 small bone and joint technologies. SBi is now a leading privately-held orthopedic company and the only one focused exclusively on technologies and treatments for the small bones & joints.
The company was recently ranked #24 on a survey conducted by Dow Jones VentureSource and published in The Wall Street Journal (both owned by News Corporation) to identify the Top 50 venture capital-backed U.S. companies. Additionally, SBi was one of the seven health-care companies and the only orthopedics company to be ranked in the Top 50.
About Small Bone Innovations, Inc.
Small Bone Innovations, Inc. (SBi) was founded in 2004 by Viscogliosi Brothers, LLC, (VB), a New York-based merchant banking firm that specializes in the musculoskeletal/orthopedics sector. VB created SBi as the first company to focus purely on small bones & joints. By integrating established companies and professionals in the field, SBi offers a broad, clinically proven portfolio of products and technologies to treat trauma and diseases in small bones & joints. Today, SBi has facilities in New York, NY, Morrisville, PA, Bourg-en-Bresse, France, Donaueschingen, Germany, and Kuala Lumpur, Malaysia.
For more information on SBi, please visit: www.totalsmallbone.com
Forward-looking statements
This news release contains forward-looking statements as defined in the U.S. Private Securities Litigation Reform Act of 1995. Readers are cautioned not to place undue reliance on these forward-looking statements. Actual results may differ materially from those indicated by these forward-looking statements as a result of risks and uncertainties impacting SBi’s business including increased competition; the ability of SBi to expand its operations and to attract and retain qualified professionals; technological obsolescence; general economic conditions; and other risks.
Contact:
Varun Gandhi
Small Bone Innovations, Inc.
P: 212.583.0370 ext. 2126
E: Email Contact
